RAYMOND JAMES & ASSOCIATES - NEXIMMUNE INC ownership

NEXIMMUNE INC's ticker is NEXI and the CUSIP is 65344D109. A total of 32 filers reported holding NEXIMMUNE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of NEXIMMUNE INC
ValueSharesWeighting
Q3 2023$67,299
-25.5%
320,6220.0%0.00%
Q2 2023$90,351
-25.8%
320,6220.0%0.00%
Q1 2023$121,836
+1536.7%
320,622
+947.0%
0.00%
Q4 2022$7,444
-56.2%
30,6220.0%0.00%
Q3 2022$17,000
-65.3%
30,6220.0%0.00%
Q2 2022$49,000
-43.7%
30,622
+48.5%
0.00%
Q1 2022$87,000
-77.9%
20,622
-20.6%
0.00%
Q3 2021$393,00025,9570.00%
Other shareholders
NEXIMMUNE INC shareholders Q3 2023
NameSharesValueWeighting ↓
EPIQ Capital Group, LLC 390,600$81,9870.04%
M28 Capital Management LP 133,442$28,0090.03%
ALLEN OPERATIONS LLC 635,934$133,5460.03%
Slate Path Capital LP 925,000$194,1580.01%
Caprock Group, LLC 103,482$21,7210.00%
WELLS FARGO & COMPANY/MN 126$260.00%
NORTHERN TRUST CORP 12,668$2,6590.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 108,143$21,6280.00%
STATE STREET CORP 22,919$4,5840.00%
View complete list of NEXIMMUNE INC shareholders